InvestorsHub Logo
Followers 23
Posts 3078
Boards Moderated 0
Alias Born 07/15/2016

Re: thehumanchessmachine post# 36991

Tuesday, 09/19/2017 8:54:38 PM

Tuesday, September 19, 2017 8:54:38 PM

Post# of 65771
Well I think it makes the lab more expensive. Pallitech gets 500k now and 1M later. 1.5M total in potential note debt. Best notes I've seen issued lately are @ 75% discount lowest pps over 15 days prior to default which could very well translate to 50%. We could be coughing up $3M in equity for a 1.5M dollar lab but 2M in a best case scenario.

It's very expensive money for sure but in this industry and at this stage of the game it appears to be the only option. Likely will remain the only option unless sessions resign and Dems take the house and senate. Even still would Trump sign rescheduling legislation?

Only other option imho would be reg a which I don't think evio has attractive enough numbers for. To do reg a and then uplist to NASDAQ could be fruitful but that's 2019 or 2020 if all goes as planned.